Home > Insider Trading > Filing (0000899243-17-025455)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1624658	Allena Pharmaceuticals Inc.	ALNA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1341382	N James Topper	C/O Allena Pharmaceuticals, Inc. One Newton Executive Park, Suite 202 Newton MA 02459		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-11-06	1,466,805	$0.00	1,466,805	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2017-11-06	1,109,159	$0.00	2,575,964	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2017-11-06	254,409	$0.00	2,830,373	No	4	C	Indirect	See Footnote
Common Stock	Acquisiton	2017-11-06	500,000	$14.00	3,330,373	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	C	Indirect	See Footnote
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2017-11-06	6,122,448	$0.00	1,466,805	$0.00
Common Stock	Series B Preferred Stock	Disposition	2017-11-06	4,629,630	$0.00	1,109,159	$0.00
Common Stock	Series C Preferred Stock	Disposition	2017-11-06	1,061,904	$0.00	254,409	$0.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Footnotes

Represents the total number of shares of Common Stock received by Frazier Healthcare VI, L.P. ("Frazier"), upon conversion of the Series A Preferred Stock, the Series B Preferred Stock and the Series C Preferred Stock in connection with the closing of the Issuer's initial public offering.
All series of Convertible Preferred Stock automatically converted into the Issuer's Common Stock on a 4.174-for-1 basis upon closing of the initial public offering of the Issuer and have no expiration date.
These shares are held directly by Frazier Healthcare VI, L.P. The general partner of Frazier Healthcare VI, L.P is FHM VI, L.P., a Delaware limited partnership. The general partner of FHM VI, L.P. is FHM VI, L.L.C., a Delaware limited liability company. The Reporting Person is one of five members of FHM VI, L.L.C. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest in such shares, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares.